NEW YORK (GenomeWeb) – Irish molecular diagnostics firm HiberGene announced today that it has received CE marking for its HG Group B Streptococcus (GBS) test for the detection of strep infection in pregnant women using rectovaginal swabs.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.